Fewer providers name prior authorization as their biggest administrative headache than did a quarter ago, and the shift points to something benefits advisors evaluating health plan and third-party administrator relationships should track closely.
The finding comes from Aetna’s Q3 2026 Provider Survey, which polled 727 US healthcare providers, including hospital system executives, physicians, nurses, pharmacists, and health IT leaders, via Morning Consult. The survey is self-commissioned by Aetna, a CVS Health company. The underlying data, however, reflects actual movement in the administrative burden conversation.
Among providers who cited administrative burden as their top challenge, 27% pointed to prior authorization as the leading contributor, down from 31% in Q2 and representing a meaningful shift from the previous quarter. That movement coincides with active regulatory pressure on prior authorization processes. The Centers for Medicare and Medicaid Services (CMS) Interoperability and Prior Authorization Final Rule requires Medicare Advantage organizations, Medicaid, and exchange plans to implement electronic prior authorization. Compliance dates run through 2026 and 2027.
In April 2026, CMS proposed extending those requirements to prescription drugs. The industry commitment running alongside that rulemaking has added pressure. Trade group America's Health Insurance Plans (AHIP) and the Blue Cross Blue Shield Association jointly committed in 2025 that at least 80% of electronic prior authorization approvals will be answered in real time by 2027, with major plans including Aetna among the signatories.
The decline in prior authorization complaints has not reduced the overall weight of administrative burden. It has changed its shape. Among providers who cited administrative burden as a top challenge, 58% now identify updating patient medical records as the biggest contributor, up five percentage points from Q2. Nearly one in three providers said providing real-time patient information is the single most important action payers could take, the top answer when providers were asked to prioritize.
As prior authorization processing migrates toward automation, the bottleneck is moving into data exchange, whether payers are making clinical and benefits information available to providers in a usable and live format. For self-funded employers, that capability varies considerably across the TPA market, and the administrative cost burden in employer-sponsored plans is already substantial, with a Commonwealth Fund survey this month finding nearly one in three employer-insured workers unable to afford the care their plan nominally covers.
The survey’s most analytically interesting finding may be providers’ stance on fraud, waste, and abuse (FWA). Nearly all respondents, or 94%, said FWA is a problem the healthcare system needs to address, and close to 60% identified lowering overall costs as the top benefit of doing so. About 30% said they want payers to use AI to flag suspicious claims or patterns, their top recommended action. Nearly nine in ten believe payers can realistically reduce up to half of all FWA annually, and about 90% said AI is already helping address the problem.
Fifty-seven percent of providers estimated that FWA costs the system between $100 billion and $499 billion annually, selecting from a range of options rather than providing free-form estimates. Independent published figures vary considerably, and the survey captures provider perception, rather than a verified total.
What is verifiable is the enforcement trajectory. The Department of Justice reported in January 2026 that fiscal year 2025 produced more than $6.8 billion in False Claims Act recoveries, the highest single-year total in the statute’s history, and more than double the prior year’s figure. The Department of Justice’s June 2026 National Health Care Fraud Takedown, meanwhile, charged 455 defendants in schemes involving more than $6.5 billion in alleged false claims, with 50 state Medicaid Fraud Control Units participating, the most in the department’s history.
That enforcement intensity is one reason the provider consensus on AI-assisted FWA detection carries weight. Historically, aggressive FWA programs have been a source of payer-provider friction, with providers pushing back against audits and claim reviews they viewed as adversarial. The survey data suggests that providers now broadly share payers’ interest in reducing FWA, in part because they recognize it as a systemic cost driver, and in part because healthcare data breaches hitting record levels have made the integrity of claims data a shared concern across the ecosystem.
The survey also reported an average payer-provider trust score of 6.0 on a 10-point scale, effectively flat from the 6.1 recorded in Q2, a significant jump from 5.4 in Q1. Aetna frames the stable Q3 score as evidence of sustained progress. Fifty percent of providers said payers make decisions that prioritize patient well-being, up two points from Q2 and six points from Q1. Fifty-two percent said payers consistently deliver on their promises, unchanged from Q2.
A 6.0 trust score is not a resounding endorsement. It reflects an industry relationship that has improved from a low base but has considerable distance to travel. Steve Nelson, executive vice president of CVS Health and president of Aetna, said in the press release that the company has “more work ahead.” What the score does indicate is that the prior authorization reforms under way have provided enough visible progress to arrest the erosion in trust that characterized the payer-provider dynamic through much of 2023 and 2024, when public scrutiny of health plan denials peaked following the December 4, 2024, killing of UnitedHealthcare CEO Brian Thompson.”
Plans and TPAs that are investing in electronic prior authorization, real-time data exchange, and AI-assisted claims integrity are moving with the regulatory and provider-expectation current. Those that are not are accumulating friction that will eventually surface in renewal negotiations and employee experience.
